Trials / Unknown
UnknownNCT05108025
DMT310-005 Topical in the Treatment of Acne Rosacea
A Study Of The Tolerability, Safety, And Efficacy Of DMT310 For The Treatment Of Acne Rosacea
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Dermata Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topical Powder | Topical Powder mixed with diluent |
| DRUG | Placebo Topical Powder | Placebo Topical Powder mixed with diluent |
Timeline
- Start date
- 2021-11-15
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2021-11-04
- Last updated
- 2022-12-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05108025. Inclusion in this directory is not an endorsement.